Wednesday, February 10, 2010, 1:20PM AEST - The Australian Stockmarket closes in 2 hours and 45 minutes.
To create a watchlist or portfolio of shares, Register

Nanosphere, Inc. (NSPH)

8:00AM AEST: 4.57 USD  Down 0.09 (1.93%)  
 MORE ON NSPH 
Quotes
HereSummary
Charts
Technical Analysis
News & Info
Company
Analyst Coverage
Ownership
Financials
 Nanosphere, Inc. (NGM:NSPH) Delayed quote dataEdit
Last Trade:4.57 USD
Trade Time: 8:00AM AEST
Change:Down 0.09 (1.93%)
Prev Close:4.66
Open:4.79
Bid:3.99 x 100
Ask:5.64 x 100
1y Target Est:7.75
Day's Range:4.53 - 4.81
52wk Range:2.71 - 8.61
Volume:62,181
Avg Vol (3m):61,279.4
Market Cap:126.36M
P/E (ttm):N/A
EPS (ttm):-1.54
Div & Yield:N/A (N/A%)
[Chart]
1d  5d  3m  6m  1y  2y  5y 
 Add NSPH to Portfolio   Download Data

 HEADLINES 
Nanosphere to Report Fourth Quarter and Year-End 2009 Results and Hold Investor Call Wednesday, February 24, 2010
GlobeNewswire (Mon, Feb 8)
Nanosphere Announces FDA Clearance to Update the Package Insert for Its Respiratory Virus Assay to Include Reactivity With Influenza A in Cultured Clinical Isolates Containing 2009 H1N1 Influenza Virus
GlobeNewswire (Wed, Nov 25)
Nanosphere Announces FDA Submission of 510(k) Documentation for Its Verigene Cardiac Troponin I Assay
GlobeNewswire (Thu, Nov 19)
NANOSPHERE INC Financials
EDGAR Online Financials (Thu, Nov 12)
NANOSPHERE INC Earnings Call scheduled for 5:00 pm ET today
CCBN (Fri, Nov 6)
NANOSPHERE INC Files SEC form 8-K, Results of Operations and Financial Condition, Change in Directors or Principal Of
EDGAR Online (Fri, Nov 6)
Nanosphere Announces Third Quarter 2009 Results
GlobeNewswire (Fri, Nov 6)
NANOSPHERE INC Files SEC form 10-Q, Quarterly Report
EDGAR Online (Fri, Nov 6)
Nanosphere, Inc. to Present at the 2009 Credit Suisse Healthcare Conference
GlobeNewswire (Tue, Oct 27)
NANOSPHERE INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits
EDGAR Online (Thu, Oct 22)
More Headlines for NSPH...

 ANALYST 
EPS Est (next year) (Dec-09) :-1.44
EPS Est (in 2 years) (Dec-10) :-1.20
Avg Rec (current)*:1.8
PEG Ratio:N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

 BUSINESS SUMMARY 
Nanosphere, Inc. develops, manufactures, and markets a molecular diagnostics platform, the Verigene System that enables genomic and protein testing on a single platform.

Full Company Profile



Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Symbol Lookup
Latest News7 Indices